{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T01:42:33Z","timestamp":1769823753601,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.oftale.2025.03.011","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T16:28:33Z","timestamp":1741364913000},"page":"219-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Retinal vasculitis associated with intravitreal bevacizumab injection: A case report"],"prefix":"10.1016","volume":"100","author":[{"given":"S.","family":"Murillo-Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Medina-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftale.2025.03.011_bib0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000486145","article-title":"Euretina Board. 2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations","volume":"239","author":"Grzybowski","year":"2018","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oftale.2025.03.011_bib0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular endothelial growth factor a in intraocular vascular disease","volume":"120","author":"Miller","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftale.2025.03.011_bib0015","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bjo.2006.099598","article-title":"The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide","volume":"90","author":"Fung","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftale.2025.03.011_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","article-title":"Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES)","volume":"246","author":"Wu","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftale.2025.03.011_bib0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/bjo.2008.138479","article-title":"Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)","volume":"93","author":"Georgopoulos","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oftale.2025.03.011_bib0030","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3341\/jkos.2013.54.12.1945","article-title":"A case of Acute Anterior Uveitis Associated with HLA-B27 Positivity after Intravitreal Injection of Bevacizumab","volume":"54","author":"Seo","year":"2013","journal-title":"J Korean Ophthalmol Soc"},{"key":"10.1016\/j.oftale.2025.03.011_bib0035","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.ophtha.2008.05.007","article-title":"Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration","volume":"115","author":"Wickremasinghe","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftale.2025.03.011_bib0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.oftal.2022.02.006","article-title":"Guidance on brolucizumab management recommendations","volume":"11","author":"Fonollosa","year":"2022","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"10.1016\/j.oftale.2025.03.011_bib0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40942-021-00307-7","article-title":"Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review","volume":"7","author":"Anderson","year":"2021","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.oftale.2025.03.011_bib0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1167\/iovs.13-11821","article-title":"Fc\u03b3 receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration","volume":"55","author":"Murinello","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oftale.2025.03.011_bib0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017870","article-title":"Bevacizumab-induced immunoglobulin A vasculitis with nephritis: a case report","volume":"98","author":"Endo","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.oftale.2025.03.011_bib0060","first-page":"1","article-title":"Occlusive Retinal Vasculitis Following Intravitreal Drug Delivery","author":"Cunningham","year":"2021","journal-title":"Ocular Immunology and Inflammation"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579425000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173579425000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T14:26:01Z","timestamp":1746109561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173579425000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2173579425000374"],"URL":"https:\/\/doi.org\/10.1016\/j.oftale.2025.03.011","relation":{},"ISSN":["2173-5794"],"issn-type":[{"value":"2173-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal vasculitis associated with intravitreal bevacizumab injection: A case report","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftale.2025.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2024.10.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Oftalmolog\u00eda.","name":"copyright","label":"Copyright"}]}}